on the basis of the different test systems for investigation of immunecompetence and tumourspecific immunity it was possible to demonstrate that patients with melanoma , especially of clinical stages ii and iii , have a weak , sometimes an anergic immune reaction against their own tumour .
C0020964
immunity
C0206120
anergic